19
Sensor100
May 2016
Healthcare
NIH Seeks Grant Applications on Cancer Exo-
some Biomarker Research
The National Institutes of Health announced that it is seeking grant applications
for projects investigating the potential of exosomes and extracellular vesicles
(EVs), as well as their cargo, as biomarkers for cancer risk assessment, detection,
diagnosis, and prognosis.
Cancer cells are known to release more exosomes than normal cells, and data
indicate that tumor-secreted exosomes can promote tumor progression, surviv-
al, invasion, and angiogenesis.As such, the analysis of exosomes isolated from the
blood or other body fluids of cancer patients could provide insight on cancer
cell biology and serve as non-invasive predictive biomarkers for early detection,
progression, and metastasis, the NIH said. Earliest Submission Date: 13 Septem-
ber 2016.
Reported by
GenomeWeb26 May
Pioneers Festival Recognizes HealthTech
Start-ups
The Pioneers Festival, held inVienna on May 24-25 is the major event for future
technologies and entrepreneurship. 500 technology start-ups showcased their
technology to almost 2000 corporate partners and investors. The Festival ranks
the company’s presenting to the top 7 and the top 70.
Among the top 70 in 2016 were:
X.Glu- the world’s first battery-less glucose meter
ambiotex- a wearable shirt to monitor heart-rate, stress
Sentio Solutions- Feel, a wristband that tracks human emotions
See the complete
Top 70 list